AGAPE ATP CORPORATION Operating Lease, Right-of-Use Asset, Amortization Expense
AGAPE ATP CORPORATION (ATPC) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $79.86 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-14
- AGAPE ATP CORPORATION operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $34.50K, a 11.88% decline year-over-year.
- AGAPE ATP CORPORATION operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $45.36K, a 21.56% increase year-over-year.
- AGAPE ATP CORPORATION operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $42.38K, a 15.53% increase year-over-year.
- AGAPE ATP CORPORATION operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $40.08K, a 9.29% increase year-over-year.
- AGAPE ATP CORPORATION operating lease, right-of-use asset, amortization expense for fiscal 2025 was $158.92K, a 13.63% increase from fiscal 2024.
- AGAPE ATP CORPORATION operating lease, right-of-use asset, amortization expense for fiscal 2024 was $139.87K, a 4.99% decline from fiscal 2023.
- AGAPE ATP CORPORATION operating lease, right-of-use asset, amortization expense for fiscal 2023 was $147.21K, a 2.19% increase from fiscal 2022.
- AGAPE ATP CORPORATION operating lease, right-of-use asset, amortization expense for fiscal 2022 was $144.06K, a 3.31% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $34.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $79.86K 10-Q · filed 2026-08-14 | $122.23K derived: sum of 3 quarters · filed 2026-08-14 | $162.32K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $45.36K 10-Q · filed 2026-05-15 | $87.74K derived: sum of 2 quarters · filed 2026-05-15 | $127.82K derived: sum of 3 quarters · filed 2026-05-15 | $166.97K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $42.38K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $82.46K derived: sum of 2 quarters · filed 2026-04-13 | $121.61K derived: sum of 3 quarters · filed 2026-08-14 | $158.92K 10-K · filed 2026-04-13 |
| 2025-09-30 | $40.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $79.23K derived: sum of 2 quarters · filed 2026-08-14 | $116.55K 10-Q · filed 2025-11-13 | $153.23K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $39.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $76.47K 10-Q · filed 2026-08-14 | $113.14K derived: sum of 3 quarters · filed 2026-08-14 | $149.82K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $37.32K 10-Q · filed 2026-05-15 | $74.00K derived: sum of 2 quarters · filed 2026-05-15 | $110.67K derived: sum of 3 quarters · filed 2026-05-15 | $144.18K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $36.68K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-13 | $73.36K derived: sum of 2 quarters · filed 2026-04-13 | $106.86K derived: sum of 3 quarters · filed 2026-04-13 | $139.87K 10-K · filed 2026-04-13 |
| 2024-09-30 | $36.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $70.18K derived: sum of 2 quarters · filed 2025-11-13 | $103.19K 10-Q · filed 2025-11-13 | $136.59K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $33.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $66.51K 10-Q · filed 2025-08-13 | $99.92K derived: sum of 3 quarters · filed 2025-08-13 | $135.39K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $33.01K 10-Q · filed 2025-05-15 | $66.42K derived: sum of 2 quarters · filed 2025-05-15 | $101.89K derived: sum of 3 quarters · filed 2025-05-15 | $140.57K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $33.41K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $68.88K derived: sum of 2 quarters · filed 2025-03-31 | $107.56K derived: sum of 3 quarters · filed 2025-03-31 | $147.21K 10-K · filed 2025-03-31 |
| 2023-09-30 | $35.47K 10-Q · filed 2023-11-14 | $74.15K derived: sum of 2 quarters · filed 2023-11-14 | $113.80K 10-Q · filed 2024-11-14 | $151.59K derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-06-30 | $38.68K 10-Q · filed 2023-08-14 | $78.33K 10-Q · filed 2024-08-14 | $116.12K derived: sum of 3 quarters · filed 2024-05-14 | $147.18K derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-03-31 | $39.67K 10-Q · filed 2024-05-14 | $77.44K derived: sum of 2 quarters · filed 2024-05-14 | $108.50K derived: sum of 3 quarters · filed 2024-05-14 | $144.66K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $37.76K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $68.82K derived: sum of 2 quarters · filed 2024-04-01 | $104.98K derived: sum of 3 quarters · filed 2024-04-01 | $144.06K 10-K · filed 2024-04-01 |
| 2022-09-30 | $31.06K 10-Q · filed 2023-11-14 | $67.22K derived: sum of 2 quarters · filed 2023-11-14 | $106.30K 10-Q · filed 2023-11-14 | $133.07K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $36.16K 10-Q · filed 2023-08-14 | $75.24K 10-Q · filed 2023-08-14 | $102.01K derived: sum of 3 quarters · filed 2023-08-14 | $139.31K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $39.08K 10-Q · filed 2023-05-15 | $65.85K derived: sum of 2 quarters · filed 2023-05-15 | $103.14K derived: sum of 3 quarters · filed 2023-05-15 | $140.92K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $26.77K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $64.06K derived: sum of 2 quarters · filed 2023-03-31 | $101.84K derived: sum of 3 quarters · filed 2023-03-31 | $139.45K 10-K · filed 2023-03-31 |
| 2021-09-30 | $37.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $75.07K derived: sum of 2 quarters · filed 2022-11-14 | $112.68K 10-Q · filed 2022-11-14 | $149.19K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $37.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $75.39K 10-Q · filed 2022-08-11 | $111.90K derived: sum of 3 quarters · filed 2022-08-11 | $149.19K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $37.61K 10-Q · filed 2022-05-13 | $74.12K derived: sum of 2 quarters · filed 2022-07-05 | $111.41K derived: sum of 3 quarters · filed 2022-07-05 | |
| 2020-12-31 | $36.51K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2022-07-05 | $73.81K derived: sum of 2 quarters · filed 2022-07-05 | $106.56K 10-K/A · filed 2022-07-05 | |
| 2020-09-30 | $37.29K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-07-05 | $70.05K 10-Q/A · filed 2022-07-05 | ||
| 2020-06-30 | $32.76K 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |